Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Poxviridae Infections Drug Industry
Figure Poxviridae Infections Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Poxviridae Infections Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Poxviridae Infections Drug
1.2.2 Downstream
Table Application Segment of Poxviridae Infections Drug
Table Global Poxviridae Infections Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Poxviridae Infections Drug Market by Type
3.1 By Type
3.1.1 CJ-40011
Table Major Company List of CJ-40011
3.1.2 24a
Table Major Company List of 24a
3.1.3 BA-368
Table Major Company List of BA-368
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Poxviridae Infections Drug Market 2016-2020, by Type, in USD Million
Figure Global Poxviridae Infections Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Poxviridae Infections Drug Market 2016-2020, by Type, in Volume
Figure Global Poxviridae Infections Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Poxviridae Infections Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Poxviridae Infections Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Bavarian Nordic A/S (Company Profile, Sales Data etc.)
4.1.1 Bavarian Nordic A/S Profile
Table Bavarian Nordic A/S Overview List
4.1.2 Bavarian Nordic A/S Products & Services
4.1.3 Bavarian Nordic A/S Business Operation Conditions
Table Business Operation of Bavarian Nordic A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 BioFactura, Inc. (Company Profile, Sales Data etc.)
4.2.1 BioFactura, Inc. Profile
Table BioFactura, Inc. Overview List
4.2.2 BioFactura, Inc. Products & Services
4.2.3 BioFactura, Inc. Business Operation Conditions
Table Business Operation of BioFactura, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 CEL-SCI Corporation (Company Profile, Sales Data etc.)
4.3.1 CEL-SCI Corporation Profile
Table CEL-SCI Corporation Overview List
4.3.2 CEL-SCI Corporation Products & Services
4.3.3 CEL-SCI Corporation Business Operation Conditions
Table Business Operation of CEL-SCI Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Chimerix, Inc. (Company Profile, Sales Data etc.)
4.4.1 Chimerix, Inc. Profile
Table Chimerix, Inc. Overview List
4.4.2 Chimerix, Inc. Products & Services
4.4.3 Chimerix, Inc. Business Operation Conditions
Table Business Operation of Chimerix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 China Biologic Products, Inc. (Company Profile, Sales Data etc.)
4.5.1 China Biologic Products, Inc. Profile
Table China Biologic Products, Inc. Overview List
4.5.2 China Biologic Products, Inc. Products & Services
4.5.3 China Biologic Products, Inc. Business Operation Conditions
Table Business Operation of China Biologic Products, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 CJ HealthCare Corp. (Company Profile, Sales Data etc.)
4.6.1 CJ HealthCare Corp. Profile
Table CJ HealthCare Corp. Overview List
4.6.2 CJ HealthCare Corp. Products & Services
4.6.3 CJ HealthCare Corp. Business Operation Conditions
Table Business Operation of CJ HealthCare Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 EpiVax, Inc. (Company Profile, Sales Data etc.)
4.7.1 EpiVax, Inc. Profile
Table EpiVax, Inc. Overview List
4.7.2 EpiVax, Inc. Products & Services
4.7.3 EpiVax, Inc. Business Operation Conditions
Table Business Operation of EpiVax, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 N & N Pharmaceuticals Inc. (Company Profile, Sales Data etc.)
4.8.1 N & N Pharmaceuticals Inc. Profile
Table N & N Pharmaceuticals Inc. Overview List
4.8.2 N & N Pharmaceuticals Inc. Products & Services
4.8.3 N & N Pharmaceuticals Inc. Business Operation Conditions
Table Business Operation of N & N Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 SIGA Technologies, Inc. (Company Profile, Sales Data etc.)
4.9.1 SIGA Technologies, Inc. Profile
Table SIGA Technologies, Inc. Overview List
4.9.2 SIGA Technologies, Inc. Products & Services
4.9.3 SIGA Technologies, Inc. Business Operation Conditions
Table Business Operation of SIGA Technologies, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Takeda Pharmaceutical Company Limited (Company Profile, Sales Data etc.)
4.10.1 Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Overview List
4.10.2 Takeda Pharmaceutical Company Limited Products & Services
4.10.3 Takeda Pharmaceutical Company Limited Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Tonix Pharmaceuticals Holding Corp. (Company Profile, Sales Data etc.)
4.11.1 Tonix Pharmaceuticals Holding Corp. Profile
Table Tonix Pharmaceuticals Holding Corp. Overview List
4.11.2 Tonix Pharmaceuticals Holding Corp. Products & Services
4.11.3 Tonix Pharmaceuticals Holding Corp. Business Operation Conditions
Table Business Operation of Tonix Pharmaceuticals Holding Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Verrica Pharmaceuticals Inc. (Company Profile, Sales Data etc.)
4.12.1 Verrica Pharmaceuticals Inc. Profile
Table Verrica Pharmaceuticals Inc. Overview List
4.12.2 Verrica Pharmaceuticals Inc. Products & Services
4.12.3 Verrica Pharmaceuticals Inc. Business Operation Conditions
Table Business Operation of Verrica Pharmaceuticals Inc. (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Poxviridae Infections Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Poxviridae Infections Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Poxviridae Infections Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Poxviridae Infections Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Poxviridae Infections Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Poxviridae Infections Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Poxviridae Infections Drug Market Concentration, in 2020
Figure Europe Poxviridae Infections Drug Market Market Concentration, in 2020
Figure Asia-Pacific Poxviridae Infections Drug MMarket Concentration, in 2020
Figure South America Poxviridae Infections Drug Market Concentration, in 2020
Figure Middle East & Africa Poxviridae Infections Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Poxviridae Infections Drug Demand in Hospital, 2016-2020, in USD Million
Figure Poxviridae Infections Drug Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure Poxviridae Infections Drug Demand in Clinic, 2016-2020, in USD Million
Figure Poxviridae Infections Drug Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Poxviridae Infections Drug Demand in Others, 2016-2020, in USD Million
Figure Poxviridae Infections Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Poxviridae Infections Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Poxviridae Infections Drug Market Growth 2021-2026, by Application, in USD Million
Figure Poxviridae Infections Drug Market Share in 2026, by Application, in USD Million
Table Poxviridae Infections Drug Demand Forecast 2021-2026, by Application, in Volume
Table Poxviridae Infections Drug Market Growth 2021-2026, by Application, in Volume
Table Poxviridae Infections Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Poxviridae Infections Drug Production 2016-2020, by Region, in USD Million
Table Poxviridae Infections Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Poxviridae Infections Drug Market 2016-2020, by Region, in USD Million
Table Global Poxviridae Infections Drug Market Share 2016-2020, by Region, in USD Million
Table Global Poxviridae Infections Drug Market 2016-2020, by Region, in Volume
Table Global Poxviridae Infections Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Poxviridae Infections Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Poxviridae Infections Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
Table North America Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Poxviridae Infections Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Poxviridae Infections Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Poxviridae Infections Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Poxviridae Infections Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Poxviridae Infections Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Poxviridae Infections Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
Table South America Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Poxviridae Infections Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Poxviridae Infections Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Poxviridae Infections Drug Market Forecast 2021-2026, by Region, in USD Million
Table Poxviridae Infections Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Poxviridae Infections Drug
2. Table Application Segment of Poxviridae Infections Drug
3. Table Global Poxviridae Infections Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of 24a
5. Table Major Company List of BA-368
6. Table Major Company List of Others
7. Table Global Poxviridae Infections Drug Market 2016-2020, by Type, in USD Million
8. Table Global Poxviridae Infections Drug Market 2016-2020, by Type, in Volume
9. Table Global Poxviridae Infections Drug Market Forecast 2021-2026, by Type, in USD Million
10. Table Global Poxviridae Infections Drug Market Forecast 2021-2026, by Type, in Volume
11. Table Bavarian Nordic A/S Overview List
12. Table Business Operation of Bavarian Nordic A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table BioFactura, Inc. Overview List
14. Table Business Operation of BioFactura, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table CEL-SCI Corporation Overview List
16. Table Business Operation of CEL-SCI Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Chimerix, Inc. Overview List
18. Table Business Operation of Chimerix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table China Biologic Products, Inc. Overview List
20. Table Business Operation of China Biologic Products, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table CJ HealthCare Corp. Overview List
22. Table Business Operation of CJ HealthCare Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table EpiVax, Inc. Overview List
24. Table Business Operation of EpiVax, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table N & N Pharmaceuticals Inc. Overview List
26. Table Business Operation of N & N Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table SIGA Technologies, Inc. Overview List
28. Table Business Operation of SIGA Technologies, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Takeda Pharmaceutical Company Limited Overview List
30. Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Tonix Pharmaceuticals Holding Corp. Overview List
32. Table Business Operation of Tonix Pharmaceuticals Holding Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Verrica Pharmaceuticals Inc. Overview List
34. Table Business Operation of Verrica Pharmaceuticals Inc. (Sales Revenue, Cost, Gross Margin)
35. Table Global Poxviridae Infections Drug Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Poxviridae Infections Drug Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Poxviridae Infections Drug Sales Volume 2016-2020, by Company, in Volume
38. Table Global Poxviridae Infections Drug Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Poxviridae Infections Drug Demand Forecast 2021-2026, by Application, in USD Million
42. Table Poxviridae Infections Drug Demand Forecast 2021-2026, by Application, in Volume
43. Table Poxviridae Infections Drug Market Growth 2021-2026, by Application, in Volume
44. Table Poxviridae Infections Drug Market Share in 2026, by Application, in Volume
45. Table Poxviridae Infections Drug Production 2016-2020, by Region, in USD Million
46. Table Poxviridae Infections Drug Production 2016-2020, by Region, in Volume
47. Table Global Poxviridae Infections Drug Market 2016-2020, by Region, in USD Million
48. Table Global Poxviridae Infections Drug Market Share 2016-2020, by Region, in USD Million
49. Table Global Poxviridae Infections Drug Market 2016-2020, by Region, in Volume
50. Table Global Poxviridae Infections Drug Market Share 2016-2020, by Region, in Volume
51. Table North America Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
52. Table North America Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
53. Table Europe Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
54. Table Europe Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
57. Table South America Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
58. Table South America Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Poxviridae Infections Drug Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Poxviridae Infections Drug Market Size 2016-2020, by Country, in Volume
61. Table Poxviridae Infections Drug Market Forecast 2021-2026, by Region, in USD Million
62. Table Poxviridae Infections Drug Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List